Lanean...
A case of primary pulmonary atypical carcinoid with EML4-ALK rearrangement
Targeted therapy has revolutionized the treatment pattern of advanced drive gene mutation positive non-small cell lung cancer (NSCLC). Advanced testing techniques enable physicians to detect these gene alterations in the clinic, thereby offering targeted therapies as treatment options to their patie...
Gorde:
| Argitaratua izan da: | Cancer Biol Ther |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7012075/ https://ncbi.nlm.nih.gov/pubmed/31559892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2019.1665957 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|